Insights into a rare genetic disease

(RIKEN) In a big step towards understanding the effects of a rare mutation, research by scientists at the RIKEN-Max Planck Joint Research Center in Japan implicates the enzyme ENGase as the factor responsible for deficient protein degradation that occurs in the absence of mouse Ngly1 gene expression.